Archives: Speakers

Tine Bülow is an established Supply Chain Project Manager with over 12 years of experience in clinical IT systems. She brings extensive expertise in integrating clinical technologies to optimize trial operations, with a strong focus on temperature management and data integrity throughout the temperature deviation process. Her background includes 8 years working with Interactive Response Technology (IRT) systems and 4 years dedicated to advanced temperature control solutions.

Tine’s work centers on safeguarding both product and data integrity across the entire supply chain—from packaging and shipment to storage at clinical sites—ensuring that patients receive safe and effective investigational products under optimal conditions. Passionate about reliability and compliance, she is committed to driving smarter, innovative solutions that strengthen quality, trustworthiness, and integrity in clinical trial delivery—ultimately protecting patient safety and improving trial outcomes.

Helén Johansen Blanco has 24 years of clinical development experience, managing Phase I to III clinical trials leading to the successful launch of several oncology products, as Revlimid, Xofigo and a Herceptin biosimilar. She has experience in project management and financial oversight of large global clinical trials conducted in all continents of the world, mainly within oncology, but also therapeutic areas as cardiovascular and gastrointestinal. Mrs. Blanco has previously worked for large international pharma companies such as AstraZeneca and Mylan, as well as small, medium to large sized biotechnology companies as Nordic Nanovector, Oncoinvent, Cantargia, Cytovation and Celgene. Currently she holds a position as Chief Operating Officer at Node Pharma AS, a small medium sized Norwegian biotech company. She holds a Diploma Engineer/MSc degree in Biophysics and medical technology and a MBA.

Dr. Alexander Debets has more than 30 years of experience in analytical and pharmaceutical R&D.

He previously worked for Organon and Schering-Plough. He held several roles of increasing responsibility in Analytical Development, Pharmaceutical Development and Clinical Supply Operations in the Netherlands. He was site head of development manufacturing sites in Germany and in Switzerland, which involved the transition of a site from research and development into commercial. He did lead the Global Clinical Supply organization at MSD in the US.

Recently he held a position of Lead Clinical Supply Innovation, driving new opportunities to enhance the clinical supply chain for patients, sites and sponsor.

His educational background includes a Doctor in Chemistry, and a Master’s Degree in Analytical🥾 Chemistry and Toxicology from the Free University, Amsterdam, the Netherlands.

He was chairman of several committees and councils, including global harmonization steering committees for Analytical Chemistry, Manufacturing and Control (CMC) processes, Quality and international Procurement Improvements. He was board-member of the Analytical Section of the Royal Dutch Chemical Society and president of the Analytical Lab Managers Association.

Charlotte Sauter is a dedicated professional in digital health. As a Principal Digital Health Scientist at Lundbeck, she brings more than four years of experience in evaluating and implementing Digital Health Technologies, including wearable devices, into clinical trials. Before joining Lundbeck, Charlotte worked as a Research Associate at NTU Singapore, focusing on digital health within the field of population health science. She holds a Bachelor’s degree in Health Economics and a Master’s degree in Global Health.

Alastair Clewlow is Senior Director for Clinical Data Management, Statistical Programming and Digital solutions at Lundbeck. He has over 25 years of experience in the pharmaceutical and IT Industry, having held positions in Data Management and Clinical Operations at LEO Pharma, Product Strategy and Development in the Oracle Health Sciences Global Business Unit before joining Lundbeck. He graduated from the University of Portsmouth with a BSc (Hons) in molecular biology.